Stockscreener 앱 받기
13.64
1.16%
-0.16
Novocure Ltd 주식(NVCR)의 최신 뉴스
NovoCure Limited (NASDAQ:NVCR) Receives Average Rating of “Hold” from Analysts - Defense World
NovoCure’s (NVCR) “Neutral” Rating Reaffirmed at Wedbush - Defense World
Assessing NovoCure: Insights From 4 Financial Analysts - Benzinga
NovoCure (NVCR) Rating Reiterated as Neutral by Wedbush | NVCR S - GuruFocus
A Look At NovoCure (NVCR) Valuation After Record 2025 Revenue And CEO Transition - simplywall.st
NovoCure (NASDAQ:NVCR) Receives Neutral Rating from Wedbush - MarketBeat
Leerink Partners Maintains Novocure(NVCR.US) With Buy Rating, Cuts Target Price to $24 - 富途牛牛
NovoCure Limited (NASDAQ:NVCR) Receives Average Rating of "Hold" from Analysts - MarketBeat
Brokers Set Expectations for NovoCure FY2030 Earnings - Defense World
HC Wainwright Comments on NovoCure FY2030 Earnings - MarketBeat
NovoCure (NASDAQ:NVCR) Given New $39.00 Price Target at HC Wainwright - Defense World
Is NovoCure (NVCR) A Rare Opportunity After A 45.9% One Year Share Price Fall - simplywall.st
Why NovoCure Is Failing To Disrupt NSCLC (NASDAQ:NVCR) - Seeking Alpha
NovoCure stock holds steady as H.C. Wainwright reiterates Buy rating By Investing.com - Investing.com Nigeria
HC Wainwright & Co. Maintains Buy Rating on NVCR, Lowers Price T - GuruFocus
HC Wainwright Has Lowered Expectations for NovoCure (NASDAQ:NVCR) Stock Price - MarketBeat
NovoCure stock holds steady as H.C. Wainwright reiterates Buy rating - Investing.com
H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Cuts Target Price to $39 - 富途牛牛
Novocure reports $655 million in preliminary 2025 revenue By Investing.com - Investing.com South Africa
Novocure (NVCR) Surpasses Revenue Expectations with Strong FY25 Performance - GuruFocus
Cancer therapy Novocure hits record sales, awaits 2026 trial results - Stock Titan
Can NovoCure Limited stock double in next 5 years2025 Bull vs Bear & Low Risk High Reward Trade Ideas - Улправда
Will NovoCure Limited stock split attract more investorsProfit Target & Safe Capital Allocation Plans - ulpravda.ru
Can NovoCure Limited stock surprise with earnings upsideEarnings Performance Report & Scalable Portfolio Growth Methods - Улправда
How NovoCure Limited stock reacts to global recession fears2025 Geopolitical Influence & Entry and Exit Point Strategies - ulpravda.ru
How analysts rate NovoCure Limited stock todayMarket Growth Report & Safe Investment Capital Preservation Plans - Улправда
Will NovoCure Limited stock outperform tech sector in 2025Portfolio Growth Summary & Community Verified Watchlist Alerts - Улправда
Total debt per share of NovoCure Ltd. – GETTEX:038 - TradingView — Track All Markets
Voya Investment Management LLC Sells 64,539,786 Shares of NovoCure Limited $NVCR - MarketBeat
NovoCure Ltd (NVCR) Product Pipeline Analysis Report 2025ResearchAndMarkets.com - Bluefield Daily Telegraph
Why NovoCure Limited stock could be next big winnerChart Pattern Recognition & View Live Stock Forecasts Instantly - bollywoodhelpline.com
NovoCure (NVCR): Assessing Valuation After a Recent Rebound From Multi‑Month Lows - Yahoo Finance UK
NovoCure (NVCR): Exploring Valuation After a Recent Share Price Rebound - simplywall.st
Has NovoCure’s Tumor Treating Fields Progress Created a Value Opportunity After the 2025 Share Slump? - Yahoo Finance
Novocure (NVCR) Q2 2025 Earnings Call Transcript - AOL.com
NovoCure (NVCR) Q3 2024 Earnings Call Transcript - The Globe and Mail
First Week of February 2026 Options Trading For NovoCure (NVCR) - Nasdaq
How to hear Novocure’s CEO speak at the J.P. Morgan healthcare event - Stock Titan
NovoCure Limited (NASDAQ:NVCR) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
CapEx per share of NovoCure Ltd. – MUN:038 - TradingView — Track All Markets
Wells Fargo Keeps Their Hold Rating on NovoCure (NVCR) - The Globe and Mail
NovoCure (NVCR): Assessing Valuation After the CEO Transition From Ashley Cordova to Frank Leonard - simplywall.st
NovoCure’s LUNAR-2 Study: A New Horizon in Lung Cancer Treatment - MSN
Does NovoCure’s (NVCR) Internal CEO Transition Reinforce or Recast Its Tumor Treating Fields Strategy? - simplywall.st
Marshall Wace LLP Sells 392,992 Shares of NovoCure Limited $NVCR - MarketBeat
NovoCure (NVCR): Assessing Valuation After a Steep Drawdown and Recent Share Price Uptick - simplywall.st
Does NovoCure's (NVCR) Insider CEO Transition Strengthen Its Long-Term Oncology Strategy Or Limit Change? - Yahoo Finance
NovoCure (NASDAQ:NVCR) Stock Price Up 7%Time to Buy? - MarketBeat
What is the fair value estimate for NovoCure Limited (038) stock in 2025Weekly Trade Report & Verified Stock Trade Ideas - Newser
Edgestream Partners L.P. Increases Holdings in NovoCure Limited $NVCR - Defense World
Is NovoCure’s 93% Five Year Share Price Slide Now Creating an Opportunity in 2025? - Yahoo Finance
NovoCure Limited $NVCR Shares Purchased by American Century Companies Inc. - MarketBeat
NovoCure stock rating reiterated at Buy by H.C. Wainwright amid CEO change - Investing.com Nigeria
0.42%
1.96%
자본화:
|
볼륨(24시간):